Information and interesting ideas

Topics posted here will be in the realm of bioanalysis and biomarkers as part of new therapeutic development, with the occasional post of scientific topics that I find interesting.

Monday, February 27, 2023

Publication: A Novel Hybridization LC-MS/MS Methodology for Quantification of siRNA in Plasma, CSF and Tissue Samples

Long Yuan, a former colleague of mine, and a few current colleagues recently published a method for double-stranded siRNA using hybridization extraction and LC-MS/MS. Long reports the first hybridization method for double stranded siRNA using conventional DNA capture probes, as well as, a peptide nucleic acid (PNA) capture probe. The PNA has a higher affinity for the siRNA and therefore, has greater recovery efficiency (and was proven experimentally). To optimize the LC-MS/MS conditions, they used the active antisense siRNA strand.  However for the calibration curve and QCs the double-stranded siSNA was used. A typical BMV validation was used. The calibration curve was 2-1000 ng/ML and the s/n at the LLOQ appeared to be >10. They tested monkey plasma, CSF and 8 different tissues. Using the PNA probe, they achieved around 90% recovery - demonstrating the viability of the approach for this and other double-stranded siRNA therapies. More details are in the article.

No comments:

Post a Comment

FDA and CMS issue statement on LDTs: Americans Deserve Accurate and Reliable Diagnostic Tests, Wherever They Are Made

This joint statement notes the evolution of Laboratory Developed Tests (LDTs) from the initial rule and approach the FDA had for oversite, a...